In the Blood Reagents price fixing case, Faruqi & Faruqi represents a proposed class of direct purchasers of blood reagent products, challenging conspiracy to fix prices, in violation of § 1 of the Sherman Act. Plaintiffs have alleged that defendants Immucor and Ortho-Clinics Diagnostics, a subsidiary of Johnson & Johnson, consolidated the market for blood reagents in the early 2000s in order to raise the price to supracompetitive levels. As a result of this alleged conspiracy, plaintiffs paid far more for blood reagents than they would have in a competitive market. Plaintiffs have settled with Ortho-Clinics Diagnostics and are in the process of seeking Court approval of the settlement in 2012.
Faruqi & Faruqi, LLP
101 Greenwood Avenue Suite 600
Jenkintown, PA 19046
Tel: (215) 277-5770
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.